Health-related quality of life, mental distress und somatopsychic symptoms in adult patients with haematological neoplasms

Recruiting

• Conditions: C92.0; C82.2; Acute myeloblastic leukaemia [AML]; Follicular lymphoma grade III, unspecified

• Registration Number: DRKS00003453
• Lead Sponsor: niversitätsklinik für Hämatologie und Onkologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-12-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

ICD-10-C-diagnosis, ECOG < 3

Exclusion Criteria

palliative treatment, ECOG > 2

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
a. Validation of the Somatic Burden Score SBS-AE<br>b. Aspects of mental health and somatopsychic symptoms in patients with haematological malignoms (e.g., general health perception, fatigue) assessed with the Medical Outcomes Study 36-Item Short Form Survey Instrument (SF-36), Patient Health Questionnaire (PHQ-D), Brief COPE and scale of general self-efficacy as longitudinal investigation: T1-at beginning of cancer treatment, T2-interim staging according to the chemotherapy protocol, T3-last discharge after treatment.

Secondary Outcome Measures

Name	Time	Method
associations between the somatic burden of chemotherapy induced adverse events and mental distress outcomes of cancer patients.